Enter Musk: The new Twitter Big Boss, Elon Musk, has proved to be a (un)surprisingly vocal advocate of the drug: In the meantime, semaglutide (aka Ozempic/Rybelsus) appears to be effective in appetite control with minor side effects Elon Musk (@elonmusk) April 24, 2022 The Neuralink co-founder seemed to suggest that Semaglutide would be a suitable alternative for the time being, as he claimed his Neuralink neural implant technology would soon be able to tackle the problem of morbid obesity as well, with experts backing his claims
Even then, the addition should be short-term with clear success criteria and a defined discontinuation timeline
3 In separate studies, the effect sizes observed with the Viking series of dual agonists were similar to those observed following treatment with tirzepatide, a dual GLP-1/GIP receptor agonist
the tirzepatide plan begins at $259 per month
It is a maths helper only and does not recommend any dose
Track your results over time